The anaplastic lymphoma kinase (ALK) gene was identified as a neuroblastoma predisposition gene in 2008 in two studies; one, a genetic linkage study across 20 families with neuroblastoma and the other, a genome-wide comparative genomic hybridization analysis of 592 neuroblastoma tumors [28,29]. The gene discussed is ALK; the disease is neuroblastoma.